CDH2 and cancer: N-cadherin is also overexpressed in advanced stages of prostate [32], colorectal [33], and ovarian [34] cancer and in the latter after stimulation of the EGFR pathway, a protein that is overexpressed in glioblastoma and could be one of the causes of the EMT phenotype in this tumor.